DEFA14A: Adaptive Biotechnologies Sets Date for Annual Shareholder Meeting, Seeks Approval on Key Proposals
Proxy Statement
Adaptive Biotechnologies will hold its annual shareholder meeting on June 10, 2025, seeking votes on director election, executive compensation, and auditor ratification.
Summary
- Adaptive Biotechnologies Corporation will hold its annual meeting of shareholders on Tuesday, June 10, 2025.
- The meeting will be held entirely via the Internet.
- Shareholders of record as of April 15, 2025, are eligible to vote.
- The board of directors recommends voting 'FOR' Proposals 1, 2, and 3.
- Proposal 1 involves electing Chad Robins as a Class III director for a three-year term expiring at the 2028 annual meeting.
- Proposal 2 is a non-binding advisory vote on the compensation of named executive officers.
- Proposal 3 seeks to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2025.
Sentiment
Score: 7
Explanation: The document is a standard proxy statement, indicating a neutral to slightly positive sentiment as it reflects the company's adherence to corporate governance practices.
Positives
- The company is providing multiple avenues for shareholders to access proxy materials and vote, including online access, phone, and email.
- Shareholders have the option to request paper copies of the proxy materials.
Future Outlook
The document outlines the agenda for the upcoming annual meeting, focusing on standard corporate governance matters.
Industry Context
This is a standard proxy statement outlining routine corporate governance matters, typical for publicly traded companies.
Stakeholder Impact
- Shareholders have the opportunity to influence the company's direction through voting.
- The outcome of the votes on director election and executive compensation will impact the company's leadership and management structure.
Next Steps
- Shareholders should review the proxy materials and vote on the proposals.
- The company will hold its annual meeting on June 10, 2025.
Key Dates
| Date | Description |
|---|---|
| April 15, 2025 | Shareholders of record date for the annual meeting |
| May 30, 2025 | Deadline to request paper proxy materials |
| June 6, 2025 | Deadline to register to attend the meeting |
| June 10, 2025 | Annual Meeting of Shareholders |
| December 31, 2025 | End of fiscal year for which Ernst & Young LLP's appointment is being ratified |
| 2028 | Year that the Class III director's term expires |
Keywords
Annual Meeting, Shareholders, Proxy Statement, Director Election, Executive Compensation, Auditor Ratification, Adaptive Biotechnologies
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.